Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Research Confirms Peptan Benefits on Bone Health - Nutraceuticals World

What are you searching for?

Sign in
Research

Research Confirms Peptan Benefits on Bone Health

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Oral intake of Peptan, from Rousselot, may have a positive impact on osteoporosis. Researchers conducted an in vivo study on ovariectomized mice, used to simulate postmenopausal osteoporosis, which leads to a lower bone mineral density (BMD).

Animals were divided into three groups: a control group (non ovariectomized), a group of ovariectomized mice, both fed with a normal diet, and a group of ovariectomized mice that received a diet containing Peptan. After 12 weeks, the BMD of the group fed with Peptan was higher. Confirmation of Peptan benefits on bone health was obtained by the measures of Carboxy Terminal Telopeptide (CTX), a usual marker of bone resorption. CTX was significantly lower in mice fed with Peptan indicating that bone resorption was reduced.

Researchers concluded that Peptan may restore bone density in simulated post-menopausal osteoporosis by stimulating osteoblast growth and differentiation. For further information: www.rousselot.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters